Rank | Keywords | Count | Centrality | Rank | Keywords | Count | Centrality |
---|---|---|---|---|---|---|---|
1 | clinical trial | 101 | 0.37 | 14 | patient | 15 | 0.03 |
2 | therapy | 62 | 0.23 | 15 | chemotherapy | 14 | 0.02 |
3 | adverse event | 52 | 0.32 | 16 | gene therapy | 13 | 0.06 |
4 | management | 51 | 0.15 | 17 | guideline | 13 | 0.02 |
5 | rare diseases | 45 | 0.11 | 18 | enzyme replacement therapy | 12 | 0.01 |
6 | efficacy | 43 | 0.09 | 19 | interstitial lung disease | 11 | 0.04 |
7 | adverse drug reaction | 39 | 0.23 | 20 | mutation | 10 | 0.05 |
8 | diagnosis | 39 | 0.09 | 21 | antibody | 10 | 0.02 |
9 | children | 30 | 0.14 | 22 | treatment outcome | 10 | 0.02 |
10 | disease | 27 | 0.12 | 23 | cancer | 10 | 0.01 |
11 | safety | 24 | 0.04 | 24 | follow up | 10 | 0.01 |
12 | risk | 17 | 0.05 | 25 | nivolumab | 10 | 0 |
13 | quality of life | 17 | 0.03 | Â | Â | Â | Â |